Supplementary Figure 2 from Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma

Autor:	Nicholas K. Foreman, Kathleen Dorris, Rajeev Vibhakar, Michael H. Handler, Todd C. Hankinson, Lindsey M. Hoffman, Jean M. Mulcahy Levy, Davis A. Witt, Andrea M. Griesinger, Elliot A. Warner, Vladimir Amani, Andrew M. Donson
Rok vydání:	2023
DOI:	10.1158/1535-7163.22505074.v1
Popis:	Apoptosis time courses for EPN cell lines 811 and 928 treated with floxuridine, bexarotene, and axitinib all at 1µM, as measured by live cell imaging (IncuCyte) ofcaspase 3/7 activation (green objects/mm2). Idarubicin (1µM) provides a positive control for apoptosis and untreated cells serve as a negative control.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a24f5660d14c9159a000724c4493f53 https://doi.org/10.1158/1535-7163.22505074.v1 Zobrazit plný text záznamu